Experience with Uralyt-U citralite used in patients with gout and nephrolithiasis

Experience with Uralyt-U citralite used in patients with gout and nephrolithiasis

Show other versions (1)

The paper gives the results of an open-label trial of the Uralyt-U citrate used in 30 patients with gout and nephrolithiasis. In addition to rapid urine pH optimization, the use of the drug is shown to cause a reduction in the serum level of uric acid, correlating with its enhanced excretion. The us...

Full description

Bibliographic Details
Main Authors: Maksim Sergeyevich Eliseyev, I S Denisov, V G Barskova
Format: Article
Language:Russian
Published: IMA-PRESS LLC 2012-09-01
Series:Современная ревматология
Subjects:
gout
uric acid
nephrolithiasis
citrates
uralyt-u
Online Access:https://mrj.ima-press.net/mrj/article/view/431
Description
Summary:The paper gives the results of an open-label trial of the Uralyt-U citrate used in 30 patients with gout and nephrolithiasis. In addition to rapid urine pH optimization, the use of the drug is shown to cause a reduction in the serum level of uric acid, correlating with its enhanced excretion. The use of the agent features good compliance and fails to affect renal functional parameters.
ISSN:1996-7012
2310-158X

Similar Items